News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,088 Results
Type
Article (87875)
Company Profile (825)
Press Release (780373)
Multimedia
Podcasts (191)
Webinars (28)
Section
Business (233219)
Career Advice (4144)
Deals (39863)
Drug Delivery (145)
Drug Development (91394)
Employer Resources (203)
FDA (18376)
Job Trends (17417)
News (397825)
Policy (39958)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (180)
Alzheimer's disease (1782)
Antibody-drug conjugate (ADC) (334)
Approvals (18543)
Artificial intelligence (611)
Autoimmune disease (154)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (489)
Bladder cancer (158)
Brain cancer (64)
Breast cancer (644)
Cancer (4903)
Cardiovascular disease (433)
Career advice (3566)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (811)
Cervical cancer (37)
Clinical research (76874)
Collaboration (1742)
Company closure (5)
Compensation (1121)
Complete response letters (70)
COVID-19 (2987)
CRISPR (96)
C-suite (822)
Cystic fibrosis (154)
Data (6127)
Decentralized trials (2)
Denatured (70)
Depression (143)
Diabetes (523)
Diagnostics (7207)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (294)
Drug pricing (218)
Drug shortages (36)
Duchenne muscular dystrophy (232)
Earnings (100027)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134937)
Executive appointments (1023)
FDA (21439)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1528)
Gene editing (210)
Generative AI (62)
Gene therapy (657)
GLP-1 (1107)
Government (5432)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (59)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (286)
Immuno-oncology (51)
Indications (83)
Infectious disease (3269)
Inflammatory bowel disease (201)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (236)
Interviews (816)
IPO (17952)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (669)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (814)
MASH (171)
Medical device (14999)
Medtech (15043)
Mergers & acquisitions (22947)
Metabolic disorders (1359)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (339)
Neuropsychiatric disorders (92)
Neuroscience (3060)
NextGen: Class of 2026 (7707)
Non-profit (5107)
Now hiring (62)
Obesity (654)
Opinion (330)
Ovarian cancer (161)
Pain (198)
Pancreatic cancer (224)
Parkinson's disease (288)
Partnered (38)
Patents (488)
Patient recruitment (452)
Peanut (60)
People (66805)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23760)
Phase II (33355)
Phase III (25145)
Pipeline (4635)
Policy (328)
Postmarket research (3554)
Preclinical (10680)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (862)
Real estate (7437)
Recruiting (80)
Regulatory (28843)
Reports (65)
Research institute (2720)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (19)
RSV (83)
Schizophrenia (157)
Series A (254)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (98)
The Weekly (119)
Vaccines (1127)
Venture capital (91)
Weight loss (450)
Women's health (84)
Worklife (21)
Date
Today (123)
Last 7 days (917)
Last 30 days (2251)
Last 365 days (33287)
2026 (1401)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (87)
Alaska (7)
Arizona (338)
Arkansas (14)
Asia (51475)
Australia (9033)
California (11299)
Canada (3251)
China (1126)
Colorado (476)
Connecticut (491)
Delaware (339)
Europe (118278)
Florida (1653)
Georgia (361)
Hawaii (3)
Idaho (68)
Illinois (938)
India (64)
Indiana (533)
Iowa (23)
Japan (412)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1437)
Massachusetts (8366)
Michigan (348)
Minnesota (647)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (85)
New Jersey (3056)
New Mexico (33)
New York (2997)
North Carolina (1582)
North Dakota (10)
Northern California (5385)
Ohio (346)
Oklahoma (22)
Oregon (54)
Pennsylvania (2264)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4350)
Tennessee (173)
Texas (1783)
United States (40895)
Utah (339)
Vermont (1)
Virginia (281)
Washington D.C. (85)
Washington State (949)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 869,088 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
AbbVie and Novartis strike billion-dollar pacts while attendees at the J.P. Morgan Healthcare Conference await that one big M&A deal and Merck teases limitless buying capacity; Eli Lilly readies for potential orforglipron launch while Novo Nordisk laments compounders; the IPO window cracks open; and the FDA concludes that GLP-1s do not pose a suicide risk.
January 14, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
January 14, 2026
·
7 min read
Press Releases
Routine FDA Inspection Reveals Zero Findings for Univo IRB
January 14, 2026
·
1 min read
Press Releases
Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate
January 14, 2026
·
4 min read
Press Releases
Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting
January 14, 2026
·
2 min read
Press Releases
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
January 14, 2026
·
8 min read
Press Releases
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
January 14, 2026
·
4 min read
Press Releases
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
January 14, 2026
·
5 min read
Press Releases
Zonsen PepLib Biotech and Novartis Sign Worldwide License Agreement regarding Radioligand Therapy Asset
January 14, 2026
·
2 min read
Press Releases
Vy Spine Announces FDA Clearance for VyBrate VBR System
January 14, 2026
·
2 min read
1 of 86,909
Next
